4168 |
北城證券研發部提供 非經同意不得轉載 本刊內容僅供參考 投資人應謹慎考量投資風險 本公司不負任何法律責任 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4168 醣聯 |
實收資本額 |
1086 (百萬) |
|
|
|
|
|
|
|
|
|
市 場
別 |
OTC |
上 櫃 日 期 |
2012/12/18 |
|
|
|
|
|
|
|
|
|
發 言
人 |
呂耀華 |
電 話 |
(02)2697-4168 |
|
|
|
|
|
|
|
|
|
地 址 |
新北市汐止區新台五路一段97號8樓 |
|
|
|
|
|
|
|
|
|
產 業
別 |
傳產-生技 |
|
|
|
|
|
|
|
|
|
主要產品 |
抗癌用之單株抗體開發、單株抗體標的授權、醣質抗原與蛋白質藥物相關委託服務 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/5/2 股價 |
18.50 |
法人買賣超合計(近一日) |
賣超 -1 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌 |
0.10
|
法人買賣超合計(近一週) |
賣超 -40.64 張 |
|
|
|
|
|
|
|
|
|
2025/5/2
漲跌幅 |
0.54
|
法人買賣超合計(近一月) |
賣超 -73.81 張 |
|
|
|
|
|
|
|
|
|
券 資 比 |
0.00
|
外資連3賣 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
最新股利發放 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
殖利率 |
|
|
|
|
|
|
|
2023/06/20 |
0.02 |
1.00 |
2014/08/12 |
2013/08/05 |
0.08% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
股利年度 |
股東會日期 |
現金股利(元) |
股票股利(元) |
除權日 |
除息日 |
扣抵率(%) |
殖利率 |
股利殖利率 |
現金殖利率 |
|
|
|
|
2024 |
2025/06/11 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2023 |
2024/06/14 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2022 |
2023/06/20 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
2021 |
2022/06/23 |
0.00 |
0.00 |
|
|
|
0% |
0% |
0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
機構估稅後EPS |
-1.84 |
K(9) |
69.74 |
|
技術面 |
技術面 |
基本面 |
基本面 |
籌碼面 |
|
|
|
|
淨值(元) |
9.63 |
D(9) |
59.21 |
評分表 |
(短線) |
(中長線) |
(安全性) |
(成長性) |
|
|
|
|
預估本益比 |
-10.05 |
周K(9) |
20.49 |
|
1.2 |
1.6 |
0.8 |
1.2 |
0 |
|
|
|
|
股價淨值比 |
1.92 |
周D(9) |
19.33 |
綜合評分: |
4.8 |
建議: |
觀望 |
目標價: |
22.65 |
|
|
|
|
月線乖離率 |
6.8 |
季線乖離率 |
-15.07 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2025/4/2 |
2025/4/11 |
2025/4/18 |
2025/4/25 |
2025/5/2 |
20*PE |
|
3*PB |
28.91 |
|
|
|
|
股價 |
21.55 |
16.90 |
16.70 |
16.45 |
18.50 |
15*PE |
|
2*PB |
19.27 |
|
|
|
|
成交量(千股) |
794 |
2,477 |
522 |
567 |
849 |
10*PE |
|
1*PB |
9.64 |
|
|
|
|
資餘 |
2,443 |
1,346 |
1,339 |
1,281 |
1,254 |
5*PE |
|
0.5*PB |
4.82 |
|
|
|
|
券餘 |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
季IFRS財報(損益單季) |
202501 |
202404 |
202403 |
202402 |
202401 |
202304 |
202303 |
202302 |
|
|
|
|
營業收入淨額(千) |
|
3,178
|
2,190
|
95 |
9,238
|
0 |
933
|
1,408
|
|
|
|
|
營業成本(千) |
|
2,249
|
1,492
|
24 |
3,615
|
0 |
423
|
943
|
|
|
|
|
營業毛利(千) |
|
929
|
698
|
71 |
5,623
|
0 |
510
|
465
|
|
|
|
|
營業費用(千) |
|
65,158
|
50,735
|
54,601
|
82,943
|
66,662
|
69,071
|
61,471
|
|
|
|
|
營業利益(千) |
|
-64,229 |
-50,037 |
-54,530 |
-77,320 |
-66,662 |
-68,561 |
-61,006 |
|
|
|
|
營業外收入及支出(千) |
|
1,406
|
5,875
|
4,539
|
4,615
|
2,967
|
8,471
|
79,484
|
|
|
|
|
稅前純益(千) |
|
-62,823 |
-44,162 |
-49,991 |
-72,705 |
-63,695 |
-60,090 |
18,478
|
|
|
|
|
所得稅(千) |
|
0 |
0 |
24 |
0 |
0 |
0 |
14,645
|
|
|
|
|
稅後純益(千) |
|
-62,823 |
-44,162 |
-50,015 |
-72,705 |
-63,695 |
-60,090 |
3,833
|
|
|
|
|
其他綜合損益(千) |
|
489
|
-3,321 |
3,779
|
-1,183 |
-589 |
-829 |
-496 |
|
|
|
|
綜合損益(千) |
|
-62,334 |
-47,483 |
-46,236 |
-73,888 |
-64,284 |
-60,919 |
3,337
|
|
|
|
|
原始每股稅前盈餘(元) |
|
-0.58 |
-0.41 |
-0.46 |
-0.67 |
-0.59 |
-0.55 |
0.17
|
|
|
|
|
原始每股稅後盈餘(元) |
|
-0.58 |
-0.41 |
-0.46 |
-0.67 |
-0.59 |
-0.55 |
0.04
|
|
|
|
|
毛利率(%) |
|
29.23
|
31.87
|
74.74
|
60.87
|
|
54.66
|
33.03
|
|
|
|
|
營業利益率(%) |
|
-2,021.05 |
-2,284.79 |
-57,400.00 |
-836.98 |
|
-7,348.45 |
-4,332.81 |
|
|
|
|
稅後純益率(%) |
|
-1,976.81 |
-2,016.53 |
-52,647.37 |
-787.02 |
|
-6,440.51 |
272.23
|
|
|
|
|
稅後權益報酬率(%) |
|
-5.83 |
-3.90 |
-4.24 |
-5.87 |
-4.87 |
-4.38 |
0.27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
月營收 |
單月營收(千) |
累計營收(千) |
單月MoM |
單月YoY |
累計YoY |
累計稅前EPS |
備註 |
近3月營收(千) |
近3月年成長 |
|
|
|
|
202504 |
0 |
0 |
0.00
|
0.00
|
0.00
|
|
|
0 |
0 |
|
|
|
|
202503 |
0 |
13,569 |
-100.00 |
0.00
|
46.87
|
|
|
13,569
|
46.87 |
|
|
|
|
202502 |
13,569 |
13,569 |
0.00
|
47.25
|
46.87
|
|
創近一年新高 |
13,712
|
48.41 |
|
|
|
|
202501 |
0 |
0 |
-100.00 |
-100.00 |
-100.00 |
|
|
3,167
|
13095.83 |
|
|
|
|
202412 |
143 |
14,701 |
-95.27 |
0.00
|
478.32
|
-2.11 |
|
3,178
|
0 |
|
|
|
|
202411 |
3,024 |
14,558 |
27390.91
|
0.00
|
472.25
|
|
|
5,187
|
505.25 |
|
|
|
|
202410 |
11 |
11,534 |
-99.49 |
0.00
|
353.38
|
|
|
2,182
|
133.87 |
|
|
|
|
202409 |
2,152 |
11,523 |
11226.32
|
151.11
|
353.30
|
-1.54 |
|
2,190
|
134.73 |
|
|
|
|
202408 |
19 |
9,371 |
0.00
|
-75.00 |
455.48
|
|
|
38 |
-93.63 |
|
|
|
|
202407 |
19 |
9,352 |
0.00
|
0.00
|
480.51
|
|
|
33 |
-97.65 |
|
|
|
|
202406 |
0 |
9,333 |
-100.00 |
-100.00 |
480.05
|
-1.13 |
|
94 |
-93.32 |
|
|
|
|
202405 |
14 |
9,333 |
-82.50 |
-98.42 |
756.24
|
|
|
94 |
-89.41 |
|
|
|
|
202404 |
80 |
9,319 |
0.00
|
0.00
|
4468.14
|
|
|
9,295
|
464650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
券商代號 |
券商名稱 |
張增減 |
買張 |
賣張 |
|
|
|
|
5380 |
第一金 |
13 |
13 |
0 |
7000 |
兆豐 |
-13 |
1 |
14 |
|
|
|
|
9600 |
富邦 |
13 |
24 |
11 |
9300 |
華南永昌 |
-10 |
0 |
10 |
|
|
|
|
9200 |
凱基 |
6 |
12 |
6 |
9800 |
元大 |
-7 |
4 |
11 |
|
|
|
|
8150 |
台新 |
6 |
6 |
0 |
9A00 |
永豐金 |
-6 |
0 |
6 |
|
|
|
|
8560 |
新光 |
4 |
5 |
1 |
5850 |
統一 |
-6 |
3 |
9 |
|
|
|
|
1480 |
美商高盛 |
2 |
2 |
0 |
7790 |
國票 |
-2 |
0 |
2 |
|
|
|
|
5260 |
美好 |
1 |
1 |
0 |
8440 |
摩根大通 |
-2 |
3 |
5 |
|
|
|
|
8580 |
聯邦商銀 |
1 |
1 |
0 |
8450 |
康和 |
-2 |
0 |
2 |
|
|
|
|
8580 |
聯邦商銀 |
1 |
1 |
0 |
8880 |
國泰 |
-1 |
1 |
2 |
|
|
|
|
6380 |
光和 |
1 |
1 |
0 |
1040 |
臺銀證券 |
-1 |
0 |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20250428 |
新兵點火之外 這兩檔生技股各擁題材飆漲停 |
|
|
|
|
20250409 |
櫃買中心公告 這2家恢復、這5家暫停融資融券交易 |
|
|
|
|
20250409 |
易飛網及臺龍4月10日恢復信用交易 典範等五家遭暫停信用交易 |
|
|
|
|
20241104 |
11月4日重要財經行事曆 |
|
|
|
|
20240818 |
醣聯生物相似藥 有進展 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股TOP15買賣超券商籌碼統計(20日) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1日籌碼集中度 |
1.2 |
|
10日籌碼集中度 |
-7 |
|
單日買賣超 |
1 |
|
|
|
5日籌碼集中度 |
-1.1 |
|
20日籌碼集中度 |
-10.5 |
|
累計買賣超 |
-737 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
個股借券統計(20日) |
千張大戶統計(20週) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
單日借賣張數 |
488 |
借券餘額 |
492 |
千張大戶戶數 |
10 |
大戶比例 |
18.91 |
|
|
|
|
|
|
|
|
|
|
|
|
更新日期: |
2025/5/2 17:48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|